All You Need to Know About Rays of Belief Ltd IPO
Quick Answer
Rays of Belief Ltd IPO is a ₹125 crore Mainboard issue opening on September 1, 2026. The current reported GMP is around ₹30, implying a 12.55% premium over the ₹239 upper price band. Investors should assess valuation and fundamentals alongside GMP.
Introduction
The Indian IPO market continues to see a steady flow of new companies across healthcare, consumer, technology and other sectors. One of the upcoming issues attracting attention is the Rays of Belief Ltd IPO, the public offering of the company operating under the healthcare and developmental-care brand Mom’s Belief.
Rays of Belief is focused on intervention and support services for children with neurodevelopmental disorders, including autism spectrum disorder, ADHD, cerebral palsy, Down syndrome and developmental delays. The company has expanded its centre network across India and is also building an international presence.
The IPO opens on September 1, 2026, and closes on September 3, 2026. With a price band of ₹227–₹239 and a minimum lot size of 62 shares, a retail investor needs ₹14,818 at the upper price band for one lot. The issue size is ₹125 crore and consists entirely of a fresh issue.
Rays of Belief Ltd IPO: Key Details
Particular | Details |
Company | Rays of Belief Limited |
Brand | Mom’s Belief |
IPO Type | Mainboard |
Issue Size | ₹125 crore |
Fresh Issue | ₹125 crore |
Offer for Sale | Nil |
Price Band | ₹227–₹239 |
Face Value | ₹10 |
Lot Size | 62 shares |
Minimum Investment | ₹14,818 |
IPO Opens | September 1, 2026 |
IPO Closes | September 3, 2026 |
Allotment | September 4, 2026 |
Listing | September 8, 2026 |
Exchanges | NSE and BSE |
Registrar | KFin Technologies |
Lead Manager | Mefcom Capital Markets |
The issue comprises up to 52.30 lakh equity shares. Since the entire issue is a fresh issue, the money raised goes to the company rather than being an offer for sale by existing shareholders.
What Does Rays of Belief Ltd Do?
Rays of Belief operates the Mom’s Belief brand and works in the developmental-care and healthcare space.
Its services are primarily designed around children with neurodevelopmental disorders. The company provides personalised intervention programmes and works with families, professionals and institutions.
As of March 31, 2026, the company had 136 centres across 57 cities in 20 states and Union Territories. Its services cover areas such as autism, ADHD, Down syndrome, cerebral palsy, intellectual and learning disabilities, and global developmental delays.
The business is interesting from an Indian-market perspective because awareness and demand for specialised developmental and behavioural healthcare services have been increasing, while access remains uneven across cities.
For example, a family in a Tier-2 Indian city may historically have had fewer specialised intervention options than a family living in Bengaluru, Mumbai, Delhi or Hyderabad. A scalable centre-based model can potentially address part of this gap.
However, investors should also understand that healthcare businesses are highly dependent on qualified professionals, service quality, regulatory compliance and the ability to maintain consistent outcomes.
Rays of Belief IPO GMP: Latest Update
How to Check Rays of Belief IPO GMP
Investors tracking Rays of Belief Ltd IPO GMP can compare the latest numbers on:
It is sensible to check the timestamp because GMP can change multiple times before the IPO opens, during subscription and before listing.
Important GMP Rule
At Trendy Traders Academy, a simple screening approach can be used:
If GMP is above 20% of the upper issue price, an investor can consider applying for an IPO, provided the fundamentals, valuation, subscription data and overall market conditions also support the decision.
This is not a guarantee of listing gains.
For Rays of Belief, the currently reported GMP of around 12.55% is below the 20% threshold. Therefore, GMP alone does not currently provide a strong listing-gain signal under this framework.
Rays of Belief IPO Financial Performance
Financial performance is particularly important because the IPO valuation is relatively high.
Financial Metric | FY24 | FY25 | FY26 |
Revenue | ₹30.76 Cr | ₹36.54 Cr | ₹82.06 Cr |
EBITDA | ₹1.49 Cr | ₹3.02 Cr | ₹11.91 Cr |
PAT | ₹0.85 Cr | ₹5.88 Cr | ₹4.96 Cr |
Net Worth | ₹5.78 Cr | ₹15.02 Cr | ₹30.81 Cr |
Borrowings | Nil | ₹4.36 Cr | ₹3.61 Cr |
Figures are based on reported consolidated/restated financial information; minor differences may appear across IPO databases because of presentation and restatement conventions.
The strongest point is revenue growth.
Revenue increased from roughly ₹30.76 crore in FY24 to ₹82.06 crore in FY26. That represents substantial expansion in two financial years.
EBITDA also increased sharply from ₹1.49 crore to ₹11.91 crore.
However, there is an important caution: PAT declined from ₹5.88 crore in FY25 to ₹4.96 crore in FY26, despite the significant increase in revenue.
That means investors should not look only at top-line growth. They should understand why profitability did not rise in line with revenue.
Rays of Belief IPO Valuation
Valuation is one of the biggest points investors need to consider.
At the upper price band of ₹239, the company is being valued at roughly ₹500 crore market capitalisation based on available IPO calculations. Reported post-issue EPS is around ₹2.37, implying a post-issue P/E of approximately 100.8 times.
Valuation Factor | Rays of Belief |
Upper IPO Price | ₹239 |
Post-IPO EPS | ~₹2.37 |
P/E | ~100.8x |
ROE/RoNW | ~21.6% |
ROCE | ~29.7% |
Debt/Equity | ~0.12x |
EBITDA Margin | ~14.6% |
The low debt-to-equity ratio is positive, while ROCE of around 29.7% indicates relatively efficient capital utilisation.
But a P/E above 100x means the market is already pricing in significant future growth.
This creates a key question:
Can Rays of Belief grow earnings rapidly enough to justify the IPO valuation?
That is more important for a long-term investor than the current GMP.
Strengths of Rays of Belief Ltd
1. Strong Revenue Growth
Revenue has grown rapidly over the last two reported financial years. Expansion from approximately ₹31 crore to ₹82 crore shows that the business has been scaling.
2. Growing Centre Network
The company had 136 centres across 57 cities and 20 states/UTs as of March 31, 2026. This gives it a sizeable operating footprint for a specialised healthcare business.
3. Low Financial Leverage
Borrowings of approximately ₹3.61 crore against net worth of ₹30.81 crore result in a relatively low debt-to-equity ratio.
4. Entire Issue Is Fresh
The ₹125 crore issue is a fresh issue, meaning the proceeds are intended to strengthen and expand the company’s operations rather than provide an exit to selling shareholders.
5. High ROCE
Reported ROCE of around 29.7% is a positive operating indicator.
Risks Investors Should Know
High Valuation
The biggest concern is valuation. A P/E of roughly 100x leaves little room for disappointment.
If earnings growth slows, the stock can experience valuation compression even if the business continues growing.
PAT Decline
Revenue more than doubled between FY25 and FY26, but PAT declined from ₹5.88 crore to ₹4.96 crore. Investors should examine the reasons behind this movement.
Dependence on Skilled Professionals
The business depends heavily on trained clinical and healthcare professionals. Hiring and retaining skilled employees can influence both growth and margins.
Lease Dependence
The company operates through leased centres. Rising rental costs or difficulties in renewing leases can affect operating economics.
International Expansion Risk
The company has exposure to the US market through its subsidiary. International operations introduce additional regulatory, operational and currency-related risks.
The company itself identifies short-term leases, dependence on skilled professionals, partner relationships and US-centre exposure among important risks.
How Will Rays of Belief Use the IPO Money?
The ₹125 crore fresh issue is intended to support business expansion and operational requirements.
Use of Funds | Approx. Amount |
New learning centres / partnership centres | ₹26.88 Cr |
Lease payments for existing Indian centres | ₹14.45 Cr |
Investment in US subsidiary | ₹10.13 Cr |
Brand awareness and outreach | ₹10.21 Cr |
Technology hardware | ₹4.44 Cr |
School collaboration centres | ₹5.54 Cr |
Centre for Excellence & Research | ₹2.45 Cr |
Upskilling Academy | ₹2.05 Cr |
General corporate purposes | ₹48.85 Cr |
The largest allocation is towards general corporate purposes, while a significant amount is earmarked for centre expansion and leases.
Rays of Belief IPO vs What Investors Should Look For
Factor | Positive | Concern |
Revenue Growth | Strong | Sustainability needs monitoring |
EBITDA Growth | Strong | Margin consistency matters |
PAT | Profitable | FY26 PAT declined |
Debt | Low | Positive |
ROCE | Strong | Needs to remain sustainable |
GMP | Positive | Below 20% currently |
Valuation | Growth premium | P/E around 100x |
Issue Structure | 100% fresh issue | No OFS |
Expansion | Large opportunity | Execution risk |
This shows why the IPO cannot be judged by GMP alone.
Should You Consider Rays of Belief Ltd IPO?
There are two different ways to approach the IPO.
For Listing-Gain Investors
The current GMP of around ₹30 represents approximately 12.55% over the upper price band. That is positive, but it is below the 20% screening level discussed earlier.
Therefore, a listing-gain investor may want to wait for:
- GMP movement
- Actual subscription figures
- QIB participation
- Market conditions
- GMP on the final day
- Broader Nifty and Sensex sentiment
For Long-Term Investors
Long-term investors should focus less on GMP and more on:
- Revenue growth
- PAT growth
- Centre-level economics
- Cash flow
- Employee costs
- Valuation
- Expansion returns
- Competitive position
The company has good growth characteristics, but the valuation demands strong future execution.
Rays of Belief IPO Important Dates
Event | Date |
Anchor Bidding | August 31, 2026 |
IPO Opens | September 1, 2026 |
IPO Closes | September 3, 2026 |
Allotment | September 4, 2026 |
Refunds | September 7, 2026 |
Demat Credit | September 7, 2026 |
Listing | September 8, 2026 |
These dates are tentative and may change according to the final issue process.
Conclusion
The Rays of Belief Ltd IPO presents an interesting combination of rapid revenue expansion, a growing healthcare-centre network, low debt and a specialised business model. Its presence across 57 cities and 20 states and Union Territories gives the company an established operating footprint, while the ₹125 crore fresh issue can support further expansion.
At the same time, investors should not overlook the valuation. With a reported post-issue P/E of around 100.8x and FY26 PAT lower than FY25, expectations are already high. The current GMP of around ₹30, or 12.55%, is positive but remains below the 20% screening level. Investors should therefore track the GMP on Chittorgarh and InvestorGain, while also checking subscription numbers and the company’s financial fundamentals before making a decision.
For Indian investors, the key takeaway is simple: Rays of Belief has a promising growth story, but the IPO price leaves limited room for execution mistakes.
Disclaimer:This article is intended for educational and informational purposes only and should not be considered investment advice, a recommendation, or a solicitation to buy or sell securities. Grey Market Premium (GMP) is unofficial, unregulated and can change significantly before listing. GMP does not guarantee the actual listing price or returns. Investors should independently study the Red Herring Prospectus, financial statements, valuation, subscription data and risk factors before applying for any IPO. Securities-market investments are subject to market risks. Investors should consult a SEBI-registered investment adviser if they require personalised investment advice.
FAQs
What is the Rays of Belief Ltd IPO price band?
The Rays of Belief IPO price band is ₹227 to ₹239 per equity share, with a lot size of 62 shares.
What is the current Rays of Belief IPO GMP?
As of August 31, 2026, InvestorGain reports a GMP of ₹30, equivalent to approximately 12.55% over the ₹239 upper price band. GMP is unofficial and can change.
When will the Rays of Belief IPO open?
The minimum retail application is one lot of 75 shares. At ₹200 per share, the minimum investment is ₹15,000.
What is the minimum investment in Rays of Belief IPO?
The minimum retail application is one lot of 62 shares. At ₹239 per share, the minimum investment is ₹14,818.
Is Rays of Belief IPO suitable for long-term investment?
The company has strong revenue growth, low debt and an expanding centre network, but its valuation is high and FY26 PAT declined. Investors should evaluate valuation, earnings growth and business risks before investing.
